University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Knowledge Base > Treatment as Prevention
Antiretroviral Treatment as HIV Prevention: Related Resources
transparent gif
arrow imageJournal Articles
arrow imageGuidelines and Best Practices
arrow imagePolicy Reports, Papers, and Briefs
arrow imagePresentations, Interviews, and Roundtable Discussions
arrow imageResearch Summaries
arrow imageLinks
grey line
Journal Articles
The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men
Juusola JL, Brandeau ML, Owens DK, Bendavid E. Ann Intern Med. 2012 Apr 17;156(8):541-50.
Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence
Celum C, Baeten JM, Curr Opin Infect Dis. 2012 Feb;25(1):51-7.
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
Grant RM, Lama JR, Anderson PL, et al. [iPrEx Study Team], N Engl J Med. 2010 Dec 30;363(27):2587-99.
Guidelines and Best Practices
Guidance on Couples HIV Testing and Counselling, Including Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples
World Health Organization (WHO), April 2012.
Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men
Morbidity and Mortality Weekly Report (MMWR). 60(03);65-68. January 28, 2011.
Policy Reports, Papers, and Briefs
Preexposure Prophylaxis with Oral Tenofovir or Tenofovir/Emtricitabine
Susa Coffey, HIV Meds Quarterly, UCSF Center for HIV Information, Summmer 2011.
Antiretrovirals Aren't Just for Treatment Anymore...Maybe
Susan Buchbinder, MD, and Albert Liu, MD. UCSF Center for HIV Information, February 2011.
HIV Treatment as Prevention
National Aidsmap, 2011.
Presentations, Interviews, and Roundtable Discussions
Treatment Guidelines and the Interface with Prevention
Paul Volberding, UCSF School of Medicine, June 1, 2011.
PrEP in 2011: Results from the iPrEx Study and Discussion of the Public Health Implications
Robert M. Grant, UCSF School of Medicine and Grant Colfax, San Francisco Department of Public Health, January 20, 2010.
Research Summaries
Biomedical Interventions: Antiretroviral Therapy as an HIV Prevention Strategy
Pre-Exposure Prophylaxis Initiative
iPrex, 2011.
Pre-Exposure Prophylaxis (PrEP)
Centers for Disease Control and Prevention (CDC), 2011.
PrEP Watch
Consortium of PrEP supporters, 2011.
Pre-Exposure Prophylaxis (PrEP)
Global Advocacy for HIV Prevention (AVAC), 2011.